iOS app Android app

Big Pharma

Expensive New Diabetes Drugs Add Nothing But Cost And Complications

Allen Frances | Posted 11.17.2016 | Science
Allen Frances

The one thing drug companies are not very good at is developing better drugs. Tried and true meds are often much better, and always much cheaper, than the hyped stuff you see on TV on get from your doctor. Be informed. 

Big Pharma Defeats Bernie Sanders-Backed Measure To Lower Drug Prices

The Huffington Post | Mollie Reilly | Posted 11.09.2016 | Politics

A ballot measure to lower prescription drug prices in California failed Tuesday after major pharmaceutical companies spent more than $100 million to d...

It's High Time To Make The FDA Safe And Effective

Deepak Chopra | Posted 10.17.2016 | Healthy Living
Deepak Chopra

  By Deepak Chopra MD, Nancy S. Cetel, MD, Joseph B. Weiss, MD, Paul J. Mills, PhD, Danielle Weiss, MD, David Brenner, MD   Few government age...

How a Beleaguered Industry Needs to Adapt - and Why it Doesn't Have a Choice

Peter Miller | Posted 10.12.2016 | Business
Peter Miller

The pharmaceutical industry has had a rough go of it lately. Between negative headlines (with the recent Mylan EpiPen controversy only the latest controversy), congressional inquiries and calls from insurers and the medical community to defend the price of medications, today's value-focused healthcare landscape presents an unprecedented set of challenges for the sector.

DEA Cutting Production Of Prescription Opioids By 25 Percent In 2017

The Huffington Post | Nick Wing | Posted 10.06.2016 | Politics

The U.S. Drug Enforcement Administration is moving to curb the national opioid epidemic by slashing the production of a number of popular prescription...

Justin Bieber Condemns Big Pharma For Blocking Medical Marijuana Laws

The Huffington Post | Landess Kearns | Posted 10.05.2016 | Entertainment

Medical marijuana advocates have a new ally ― and he’s tweeting his support to a massive audience. Justin Bieber criticized pharmaceutical compani...

Important Health Stories You May Have Missed

David Michael Conner | Posted 09.27.2016 | Healthy Living
David Michael Conner

In other words, just as with our diets, we have to start to think about what information we consume and not mindlessly absorb it into our bodies and our brains.

Innovation and Regulation in Pharmaceuticals

Adam Grossman | Posted 09.15.2016 | Impact
Adam Grossman

I am a caregiver and patient advocate for my mom. I am also a proud co-founder of Give to Cure. My dynamic and awesome co- founder, Lou Reese, is a pa...

Monsanto Is Selling Itself For $66 Billion In Pesticide Megamerger

Reuters | Alexander C. Kaufman | Posted 09.14.2016 | Business

NEW YORK/FRANKFURT (Reuters) - German drugs and crop chemicals company Bayer has won over U.S. seeds firm Monsanto with an improved takeover offer of ...

Mylan Is Proof That Big Business Picks America's Pockets While Gov't Mostly Looks Away

Michael Winship | Posted 08.31.2016 | Politics
Michael Winship

Cash and carry has become nothing more than standard operating procedure in politics and government, and it's wrecking the republic. The whole system is rotten to the core, corrupted by big business and special interests from the seventh son to the seventh son.

Making America Pain-Free For Plutocrats And Big Pharma, But Not Vets

Ann Jones | Posted 08.25.2016 | Politics
Ann Jones

A Vietnam vet told me about a veteran of the Iraq War who, when some civilian said, "Thank you for your service," replied: "I didn't serve, I was used." In fact, there are many ways today's veterans are used, conned, and exploited by big gamers right here at home.

Pharma Giant Finally Spending Its Money On Drugs, Not Tax Dodges

The Huffington Post | Alexander C. Kaufman | Posted 08.24.2016 | Business

Pfizer went on a shopping spree this week, spending nearly $15.6 billion on two acquisitions to boost its array of cancer drugs and antibiotics. The V...

Number Of Registered Lobbyists Plunges As Spending Declines Yet Again

OpenSecrets Blog | Posted 08.09.2016 | Politics
OpenSecrets Blog

The lobbying industry may start arguing for its own bailout bill, given the relentless decline in reported spending for its services.

Many Commonly Used Drugs Are Useless

Allen Frances | Posted 08.07.2016 | Science
Allen Frances

Some medications are life saving. I am so thankful for the trusty med that tames my atrial fibrillation. Many meds are helpful -- demonstrating super...

Monopolies & Elitism: 5 Ways You Might Be the Elitist You Abhor

Robert Hall | Posted 07.25.2016 | Business
Robert Hall

In an age where we talk incessantly about the virtues of equality, local empowerment, engagement, freedom of choice, small business and democracy, the forces of monopoly seem to be gaining ground, sowing elitist seeds that make society's relationships more volatile. Surely none of us play a role in all of this - or do we?

Here's How It Works: Industry, Lawmakers And Money Mingle In Cleveland

OpenSecrets Blog | Posted 07.20.2016 | Politics
OpenSecrets Blog

In the tranquility of the Cleveland Botanical Gardens on Wednesday, Paul Ryan stressed the need to coordinate and strengthen the Republican party on the federal, state, and local levels. His audience? A bevy of state legislative leaders rubbing elbows with industry interests.

The Congressional Blacklist

Judy Frankel | Posted 07.18.2016 | Politics
Judy Frankel

2016 will be different. First, more voters will be coming to the polls because of the Presidential election. Second, they will be better educated because there is now a blacklist of the most heinous vote-against-the-public, vote-for-the-funders offenders.

Is There A Sustainability Imperative For The Healthcare Industry?

Lisa Xia | Posted 07.05.2016 | Impact
Lisa Xia

Healthcare, as we know it, is simply not sustainable. With growing realities including escalating costs shifting market access models; stakeholder and...

The Perils Of Polypharmacy

Allen Frances | Posted 06.21.2016 | Science
Allen Frances

Polypharmacy was once the exception in psychiatry, now it seems to have become the rule. Patients frequently are taking 3,4, even 5 psych meds at one time. And often it's primary care doctors, not psychiatrists, who are doing the prescribing -- usually without adequate training in psychiatry.

Colombia Fears U.S. May Reject Peace Plan To Protect Pharma Profits

The Huffington Post | Zach Carter | Posted 05.17.2016 | Politics

WASHINGTON -- The Colombian Embassy is concerned that lowering the price of a major cancer drug may jeopardize American funding for peace talks in the...

Big Pharma Just Bet $10 Billion On A Cancer Drug Startup. Here's Why.

The Huffington Post | Ryan Grenoble | Posted 05.10.2016 | Business

Question: What do WhatsApp and a little-known (until recently) cancer research startup named Stemcentrx have in common? Answer: They're the top two la...

Here's How Congress Is Helping Big Pharma Keep Drug Prices High

The Huffington Post | Jonathan Cohn | Posted 04.29.2016 | Politics

If you want to know why it’s so hard to fight the pharmaceutical industry and reduce spending on prescription drugs, pay close attention to a new Ob...

Mom Without Memories

Adam Grossman | Posted 04.28.2016 | Impact
Adam Grossman

My mother, who was once the primary caretaker of her husband and three kids, who worked as a substitute teacher and part time editor of the Harvard Business Review, who threw amazing parties and volunteered at the temple and ran a gourmet catering business in her spare time, has Alzheimer's Disease, just as her mother and brother had it before her.

Where Bernie Sanders' Health Care Crusade Might Go From Here

The Huffington Post | Jonathan Cohn | Posted 04.24.2016 | Politics

Bernie Sanders can make a real difference in the causes he’s championed, even if he doesn’t become president. That’s particularly true for one ...

We Stopped Pfizer's Tax Dodge, Now Let's End the Buybacks

William Lazonick | Posted 04.08.2016 | Business
William Lazonick

Now that new Treasury Department rules have effectively thwarted Pfizer's attempt to evade its U.S. tax obligations, it's time policymakers turned their attention to something far more common -- and even more damaging.